DE69816987D1 - Verfahren und zusammenstellungen zur identifiezierung von genetisch resistenten schweinen gegen f18 e. coli assozierte krankheiten - Google Patents
Verfahren und zusammenstellungen zur identifiezierung von genetisch resistenten schweinen gegen f18 e. coli assozierte krankheitenInfo
- Publication number
- DE69816987D1 DE69816987D1 DE69816987T DE69816987T DE69816987D1 DE 69816987 D1 DE69816987 D1 DE 69816987D1 DE 69816987 T DE69816987 T DE 69816987T DE 69816987 T DE69816987 T DE 69816987T DE 69816987 D1 DE69816987 D1 DE 69816987D1
- Authority
- DE
- Germany
- Prior art keywords
- swine
- coli
- resistant
- compositions
- susceptible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 241000282887 Suidae Species 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 241000282898 Sus scrofa Species 0.000 abstract 5
- 241000588724 Escherichia coli Species 0.000 abstract 3
- 102000054765 polymorphisms of proteins Human genes 0.000 abstract 3
- 230000035945 sensitivity Effects 0.000 abstract 2
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 102100039835 Galactoside alpha-(1,2)-fucosyltransferase 1 Human genes 0.000 abstract 1
- 102100040837 Galactoside alpha-(1,2)-fucosyltransferase 2 Human genes 0.000 abstract 1
- 101000893710 Homo sapiens Galactoside alpha-(1,2)-fucosyltransferase 2 Proteins 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 108010079306 galactoside 2-alpha-L-fucosyltransferase Proteins 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 208000028774 intestinal disease Diseases 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4718197P | 1997-05-20 | 1997-05-20 | |
| US47181P | 1997-05-20 | ||
| PCT/US1998/010318 WO1998053102A1 (en) | 1997-05-20 | 1998-05-20 | Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69816987D1 true DE69816987D1 (de) | 2003-09-11 |
| DE69816987T2 DE69816987T2 (de) | 2004-07-08 |
Family
ID=21947500
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69816987T Expired - Fee Related DE69816987T2 (de) | 1997-05-20 | 1998-05-20 | Zusammensetzungen zur identifizierung von scweinen, die genetisch gegen f18 e. coliassoziierte krankheiten resistent sind. |
| DE0985052T Pending DE985052T1 (de) | 1997-05-20 | 1998-05-20 | Verfahren und zusammenstellungen zur identifiezierung von genetisch resistenten schweinen gegen f18 e. coli assozierte krankheiten |
| DE69832306T Expired - Fee Related DE69832306T2 (de) | 1997-05-20 | 1998-05-20 | Verfahren und Zusammensetzungen zur Identifizierung von Schweinen, die genetisch resistent gegenüber E. Coli F18-assoziierten Krankheiten sind |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE0985052T Pending DE985052T1 (de) | 1997-05-20 | 1998-05-20 | Verfahren und zusammenstellungen zur identifiezierung von genetisch resistenten schweinen gegen f18 e. coli assozierte krankheiten |
| DE69832306T Expired - Fee Related DE69832306T2 (de) | 1997-05-20 | 1998-05-20 | Verfahren und Zusammensetzungen zur Identifizierung von Schweinen, die genetisch resistent gegenüber E. Coli F18-assoziierten Krankheiten sind |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US6596923B1 (de) |
| EP (1) | EP0985052B1 (de) |
| JP (2) | JP3637420B2 (de) |
| CN (1) | CN1314953A (de) |
| AT (2) | ATE246731T1 (de) |
| AU (2) | AU737862B2 (de) |
| BR (1) | BR9809137A (de) |
| CA (1) | CA2290768C (de) |
| CZ (1) | CZ298021B6 (de) |
| DE (3) | DE69816987T2 (de) |
| DK (2) | DK0985052T3 (de) |
| ES (2) | ES2203958T3 (de) |
| HK (1) | HK1040097A1 (de) |
| HU (1) | HUP0103587A3 (de) |
| MX (1) | MXPA99011988A (de) |
| NO (1) | NO996373L (de) |
| NZ (1) | NZ501886A (de) |
| PL (1) | PL195890B1 (de) |
| PT (1) | PT985052E (de) |
| RU (1) | RU2204609C2 (de) |
| WO (2) | WO1998053102A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE246731T1 (de) * | 1997-05-20 | 2003-08-15 | Biotechnology Res & Dev | Verfahren und zusammenstellungen zur identifiezierung von genetisch resistenten schweinen gegen f18 e. coli assozierte krankheiten |
| US6355859B1 (en) * | 1997-05-20 | 2002-03-12 | Biotechnology Research And Development Corporation | Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease |
| HU221664B1 (hu) * | 1999-03-31 | 2002-12-28 | MTA Állatorvostudományi Kutatóintézete | Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás |
| GB0118549D0 (en) * | 2001-07-30 | 2001-09-19 | Pig Improvement Uk Ltd | Methods |
| JP2006506991A (ja) | 2002-11-25 | 2006-03-02 | デン・コンゲリエ・ヴェテリネー−オ・ランボホイスコレ | ブタ多型およびその検出のための方法 |
| ZA200506094B (en) | 2002-12-31 | 2006-11-29 | Mmi Genomics Inc | Compositions, methods and systems for inferring bovine traits |
| CN104982387B (zh) * | 2015-05-25 | 2018-01-23 | 广东温氏食品集团股份有限公司 | 一种muc13和fut1基因的分子标记辅助选择方法 |
| EP3344282B8 (de) * | 2015-09-02 | 2020-12-23 | DuPont Nutrition Biosciences ApS | Glycosidhydrolasen und deren verwendung zur vorbeugung und/oder behandlung einer pathogenen infektion bei einem tier |
| CN106480174B (zh) * | 2016-09-14 | 2019-04-16 | 扬州大学 | 一种用于猪抗病育种的遗传分子标记方法和应用 |
| CN108384865A (zh) * | 2018-02-07 | 2018-08-10 | 扬州大学 | Alpha菌毛基因在仔猪腹泻致病性大肠杆菌监测、鉴别中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK41885A (da) | 1985-01-31 | 1986-11-13 | Slagteriernes Forskningsinst | 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen |
| ZA9110087B (en) | 1990-12-21 | 1992-10-28 | Univ Toronto | Diagnosis for porcine malignant hyperthermia |
| US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| US5552144A (en) | 1992-01-22 | 1996-09-03 | Microcarb, Inc. | Immunogenic shiga-like toxin II variant mutants |
| WO1994013811A1 (en) | 1992-12-04 | 1994-06-23 | N.V. Innogenetics S.A. | New polypeptides, nucleic acid sequences encoding them, and their use to prevent the adhesion of f107-fimbriated bacteria |
| US5625124A (en) * | 1994-07-11 | 1997-04-29 | Washington University | Animal model for helicobacter pylori infection |
| WO1996028967A1 (fr) | 1995-03-17 | 1996-09-26 | Chihiro Koike | Mammiferes transgeniques autres que des primates, ou des serotypes de primates superieurs ont ete exprimes par un transfert de genes etrangers et procede pour creer ceux-ci |
| ATE246731T1 (de) * | 1997-05-20 | 2003-08-15 | Biotechnology Res & Dev | Verfahren und zusammenstellungen zur identifiezierung von genetisch resistenten schweinen gegen f18 e. coli assozierte krankheiten |
| US6355859B1 (en) * | 1997-05-20 | 2002-03-12 | Biotechnology Research And Development Corporation | Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease |
| MXPA01009447A (es) * | 1999-03-19 | 2003-08-19 | Stonecraft Llc | Composicion de cemento y polimero, y metodo para fabricar el mismo. |
-
1998
- 1998-05-20 AT AT98923570T patent/ATE246731T1/de not_active IP Right Cessation
- 1998-05-20 PT PT98923570T patent/PT985052E/pt unknown
- 1998-05-20 PL PL98364701A patent/PL195890B1/pl unknown
- 1998-05-20 DK DK98923570T patent/DK0985052T3/da active
- 1998-05-20 AU AU75832/98A patent/AU737862B2/en not_active Ceased
- 1998-05-20 CZ CZ0460799A patent/CZ298021B6/cs not_active IP Right Cessation
- 1998-05-20 NZ NZ501886A patent/NZ501886A/en unknown
- 1998-05-20 WO PCT/US1998/010318 patent/WO1998053102A1/en active IP Right Grant
- 1998-05-20 AT AT03001366T patent/ATE309392T1/de not_active IP Right Cessation
- 1998-05-20 MX MXPA99011988A patent/MXPA99011988A/es active IP Right Grant
- 1998-05-20 DE DE69816987T patent/DE69816987T2/de not_active Expired - Fee Related
- 1998-05-20 CA CA002290768A patent/CA2290768C/en not_active Expired - Lifetime
- 1998-05-20 JP JP55057998A patent/JP3637420B2/ja not_active Expired - Fee Related
- 1998-05-20 ES ES98923570T patent/ES2203958T3/es not_active Expired - Lifetime
- 1998-05-20 BR BR9809137-9A patent/BR9809137A/pt not_active Application Discontinuation
- 1998-05-20 RU RU99127287/13A patent/RU2204609C2/ru not_active IP Right Cessation
- 1998-05-20 DE DE0985052T patent/DE985052T1/de active Pending
- 1998-05-20 CN CN98807387A patent/CN1314953A/zh active Pending
- 1998-05-20 DE DE69832306T patent/DE69832306T2/de not_active Expired - Fee Related
- 1998-05-20 WO PCT/US1998/010259 patent/WO1998053101A2/en active Application Filing
- 1998-05-20 ES ES03001366T patent/ES2248647T3/es not_active Expired - Lifetime
- 1998-05-20 DK DK03001366T patent/DK1310570T3/da active
- 1998-05-20 EP EP98923570A patent/EP0985052B1/de not_active Expired - Lifetime
- 1998-05-20 HU HU0103587A patent/HUP0103587A3/hu unknown
- 1998-05-20 AU AU75807/98A patent/AU7580798A/en not_active Withdrawn
-
1999
- 1999-11-19 US US09/443,766 patent/US6596923B1/en not_active Expired - Lifetime
- 1999-12-21 NO NO996373A patent/NO996373L/no unknown
-
2001
- 2001-04-27 US US09/844,705 patent/US6965022B2/en not_active Expired - Lifetime
- 2001-07-25 US US09/844,268 patent/US7193072B2/en not_active Expired - Fee Related
-
2002
- 2002-03-05 HK HK02101688.3A patent/HK1040097A1/zh unknown
-
2004
- 2004-10-13 JP JP2004299458A patent/JP3941956B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baba et al. | A novel allelic variant of serum amyloic A, SAA1γ: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA–amyloidosis | |
| Gutiérrez-Gil et al. | Genetic effects on coat colour in cattle: dilution of eumelanin and phaeomelanin pigments in an F2-Backcross Charolais× Holstein population | |
| Jeschke et al. | A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated β-myosin heavy chain genes | |
| WO2020133233A1 (zh) | 一种成骨发育不全疾病的致病突变及其检测试剂 | |
| Gossner et al. | Exploring the abomasal lymph node transcriptome for genes associated with resistance to the sheep nematode Teladorsagia circumcincta | |
| DE69735939D1 (de) | Fhit proteine und nukleinsäuren sowie darauf basierende verfahren | |
| DE69816987D1 (de) | Verfahren und zusammenstellungen zur identifiezierung von genetisch resistenten schweinen gegen f18 e. coli assozierte krankheiten | |
| DE60328959D1 (de) | Auswahl von Tieren für gewünschte genotypische und potentielle phänotypische Eigenschaften auf der Basis eines einzelnen Nukleotidpolymorphismus (SNP) im Intron 3 des IGF2-Gens | |
| JP2002512511A (ja) | 遺伝子組成物および方法 | |
| Roberts | Molecular genetics. Therapy or terror? | |
| RU99127287A (ru) | Способы и композиции для идентификации свиней, генетически резистентных к заболеваниям, ассоциированным с f18e. coli | |
| WO2003026488A3 (en) | Diagnosis and treatment of vascular disease | |
| DE69833104D1 (de) | Glaukom diagnose und behandlung | |
| MX2010008585A (es) | Prediccion y diagnosis de mielopatia degenerativa canina. | |
| Nakamura et al. | A novel variant of transthyretin (Glu89Lys) associated with familial amyloidotic polyneuropathy | |
| Fu et al. | Investigation of JAK1 and STAT3 polymorphisms and their gene–gene interactions in nonspecific digestive disorder of rabbits | |
| WO2000042196B1 (en) | Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, cancer, and down's syndrome | |
| US20040191774A1 (en) | Endothelin-1 promoter polymorphism | |
| KR102168332B1 (ko) | 망막색소변성증의 진단에 이용 가능한 15개의 ush2a 유전자 돌연변이체 및 이외 용도 | |
| WO2002086113A3 (en) | Enzyme and snp marker for disease | |
| CA2804923A1 (en) | Assays for detecting wdr62 mutations | |
| US6372900B1 (en) | Horse endothelin-B receptor gene and gene products | |
| JP3448632B2 (ja) | 古典的ｍｈｃクラスｉ抗原をコードする遺伝子 | |
| WO2000056922A3 (en) | Genetic polymorphism and polymorphic pattern for assessing disease status, and compositions for use thereof | |
| CN104293813B (zh) | 皮肤剥脱综合征新的致病基因及其编码蛋白质和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE |
|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: BIOTECHNOLOGY RESEARCH AND DEVELOPMENT CORP., PEOR Owner name: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE Owner name: SWISS FEDERAL INSTITUTE OF TECHNOLOGY ZURICH, ZüRI |
|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |